Precision Medicine News and Research

RSS

N-abling the acceleration of the life sciences through precision dispensing

In this interview, we speak to Holger Eickhoff, CEO and Founder of Scienion, about their latest technology, The Nucleus Automation Ecosystem.

From SCIENION GmbH 4 Apr 2023

Owlstone Medical launches OMED Health to enable patients to better understand their gut microbiome and manage their digestive health

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the launch of OMED Health, a dedicated, patient-centric brand and digital platform that will offer patients and clinicians access to breath-based diagnostic tests, point-of-care (PoC) devices and support resources for a range of conditions. Initially focused on digestive disease, OMED Health will help individuals with gut health issues have an improved quality of life by enabling better, and faster, understanding and management of their conditions.

From Owlstone Medical Ltd 4 Apr 2023

Yale-led team creates new resource that is an important step toward personalized care

Each person has about 4 million sequence differences in their genome relative to the reference human genome.

3 Apr 2023

Targeting bad bacteria and the immune system in isolation may help fight deadly infections

Twenty to 50 per cent of all critically ill patients contract potentially deadly infections during their stay in the intensive care unit or in hospital after being in the ICU – markedly increasing the risk of death.

31 Mar 2023

New microfluidic device quickly and automatically predicts the effectiveness of cancer treatment

One of the great challenges in the fight against cancer is to design new technologies for a personalized treatment for each patient.

31 Mar 2023

$3.2 million grant aids in the study of genetic testing approach to close racial disparity gaps in cancer care

With the aid of a near $3.2 million National Cancer Institute grant (R01CA277599) recently awarded, investigators from the state's leading cancer program, Rutgers Cancer Institute of New Jersey,  and Georgetown University's Lombardi Comprehensive Cancer Center, both NCI-designated Comprehensive Cancer Centers, will work to close racial disparity gaps in cancer care delivery by examining a novel approach to genetic testing and care based on community-identified needs.

30 Mar 2023

Synthetic hydrogel-based lymphoma tumor model paves way for personalized cancer therapies

In recent years, innovative cancer drugs that target specific molecular drivers of the disease have been embraced as the treatment of choice for many types of cancer.

29 Mar 2023

Nuclear medicine brain imaging can help evaluate the biological changes that cause chemo-brain

A newly published literature review sheds light on how nuclear medicine brain imaging can help evaluate the biological changes that cause chemotherapy-related cognitive impairment (CRCI), commonly known as chemo-brain.

28 Mar 2023

New statement suggests next steps to interpret incidentally identified gene variants related to heart disease

Increasing use of genetic testing means people may discover they have a gene variant associated with some types of cardiovascular disease (CVD).

27 Mar 2023

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

In this interview, NewsMedical speaks with Dr. Yuying Wang, R&D Director (Oncology), from BGI Genomics, about colorectal cancer and the development and application of COLOTECT® 1.0, a non-invasive fecal DNA test for the detection of colorectal cancer and pre-cancerous lesions.

From BGI Genomics 27 Mar 2023

Advancements in understanding and treating breast cancer

Researchers describe recent advancements in breast cancer research.

26 Mar 2023

mNGS outperforms microbiological tests to diagnose bloodstream infections – BGI Insight

Next-generation sequencing (mNGS) leverages genetic testing advantage to save more lives; twice as effective at identifying infection cases.

From BGI Genomics 24 Mar 2023

New KITHealthTech aims to push digitalization in the healthcare sector

Digitalization does not only affect private life and work, but also influences and changes the entire healthcare sector. Sustainable progress in medical technology to preserve health will require increased collaboration of citizens, physicians, and researchers in future.

21 Mar 2023

Decreased viral infection severity in females may be due to extra copy of X chromosome-linked gene

It has long been known that viral infections can be more severe in males than females, but the question as to why has remained a mystery – until possibly now.

17 Mar 2023

Detecting tissue-resident memory T cells in solid tumors

In this interview, NewsMedical talks with Cerba Research about in situ multiplex analysis of regulatory and effector T cells in tumors.

16 Mar 2023

How to assess clinical response in multiple myeloma

In this interview, Cerba Research explains how its teams were able to assess clinical response in multiple myeloma (MM) patients that were receiving monoclonal antibodies treatment,

From Cerba Research 16 Mar 2023

One-Pot-LAMP: A promising tool for non-small cell lung cancer diagnosis

Researchers assessed the efficiency of a genetic decoding system for diagnosing non-small cell lung cancer (NSCLC).

16 Mar 2023

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

KAIST (President Kwang Hyung Lee) announced on the 16th that an advanced AI-based drug interaction prediction technology developed by the Distinguished Professor Sang Yup Lee's research team in the Department of Biochemical Engineering that analyzed the interaction between the PaxlovidTM ingredients that are used as COVID-19 treatment and other prescription drugs was published as a thesis.

16 Mar 2023

Point-of-care test identifies patients who may benefit from hypnosis interventions for pain treatment

Hypnosis is an effective treatment for pain for many individuals but determining which patients will benefit most can be challenging. Hypnotizability testing requires special training and in-person evaluation rarely available in the clinical setting.

15 Mar 2023

Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection

Owlstone Medical, the global leader in Breath Biopsy® announced that it has entered into a Research Agreement with Bicycle Therapeutics plc.

15 Mar 2023

Precision Medicine News and Research

N-abling the acceleration of the life sciences through precision dispensing

Owlstone Medical launches OMED Health to enable patients to better understand their gut microbiome and manage their digestive health

Yale-led team creates new resource that is an important step toward personalized care

Targeting bad bacteria and the immune system in isolation may help fight deadly infections

New microfluidic device quickly and automatically predicts the effectiveness of cancer treatment

$3.2 million grant aids in the study of genetic testing approach to close racial disparity gaps in cancer care

Synthetic hydrogel-based lymphoma tumor model paves way for personalized cancer therapies

Nuclear medicine brain imaging can help evaluate the biological changes that cause chemo-brain

New statement suggests next steps to interpret incidentally identified gene variants related to heart disease

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

Advancements in understanding and treating breast cancer

mNGS outperforms microbiological tests to diagnose bloodstream infections – BGI Insight

New KITHealthTech aims to push digitalization in the healthcare sector

Decreased viral infection severity in females may be due to extra copy of X chromosome-linked gene

Detecting tissue-resident memory T cells in solid tumors

How to assess clinical response in multiple myeloma

One-Pot-LAMP: A promising tool for non-small cell lung cancer diagnosis

AI-based drug interaction prediction technology analyzes the interaction between Paxlovid ingredients

Point-of-care test identifies patients who may benefit from hypnosis interventions for pain treatment

Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News